Fapon Empowers Indian IVD Manufacturers at Medical Fair India 2024

March 14, 2024 02:35 PM AEDT | By Cision

Google News:

Fapon Empowers Indian IVD Manufacturers at Medical Fair India 2024 — Image source: Kalkine Media

Recent News

African Gold (ASX:A1G) Delivers 119% Resource Boost at Côte d’Ivoire P...

Materials Sector Faces Heat While Westgold Resources (ASX:WGX) Shines...

Solis Minerals Uncovers IOCG-Style Mineralisation in Peru, Fueling Exc...

Ionic Rare Earths (ASX:IXR) Sets Sights on US Magnet Recycling Plants...

DONGGUAN, China, March 14, 2024 /PRNewswire/ -- Fapon, a global leading life sciences company, continues its commitment in empowering the Indian IVD industry at Medical Fair India 2024, which is held from March 13 to 15 at Mumbai, India. As one of the most significant medical trade fairs in India, the event provides a crucial platform for Fapon to showcase its innovative IVD technologies and one-stop solutions tailored for IVD manufacturers.

Fapon team in the Medical Fair India 2024

During the event, Fapon is introducing novel and innovative IVD products, technologies and solutions to the Indian market. These offerings include new biomarkers, blockers, bulk reagents, assays and instrument platforms, all aimed at addressing the evolving needs of the local healthcare industry.

Dedicated to supporting local IVD partners, including the industry's leading players, Fapon is leveraging its comprehensive one-stop solutions to facilitate the development of the local IVD industry. These solutions include key raw materials, reliable bulk reagents, open-instrument platforms, customization services, and technical assistance that will collectively enable Indian IVD companies to develop advanced diagnostic tests efficiently and effectively.

With a track record of reliability and collaborative efforts in India, Fapon has become one of the most trusted IVD suppliers in the industry. Its deep industry knowledge and guided insights have facilitated local manufacturers in overcoming complex development challenges as well as accelerating the innovation of IVD products in the local market.

"Fapon is committed to bolstering the growth of the Indian IVD industry," shares Dr. Sandeep K. Vashist, Senior Global IVD Product Director at Fapon Biotech Inc. "We are proud to empower manufacturers with our comprehensive solutions, enabling them to improve the local diagnostic capabilities which will positively impact the quality of patient care in India."

About Fapon

Fapon is a global leading life sciences company dedicated to providing integrated solutions and services for diagnostics, biopharma and biotherapy. Integrating a one-stop solution on raw materials, reagents and innovative open instrument platforms, the Company has grown into a leading supplier in in-vitro diagnostics. Fapon boasts advanced innovations in therapeutics technologies and AI algorithm platforms with data insights that contribute to a better and healthier world. Supported by its strong global R&D, manufacturing, sales and service network, Fapon's products have established presence in 68 countries and regions, serving more than 2,500 business partners worldwide.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.